Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|February 10, 2022
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal CancerYuanyi Yue, Qiang Zhang, Zhengrong SunChinese Medical Journal|February 22, 2022
Clusterin as a serum biomarker candidate contributes to the lung fibroblasts activation in chronic obstructive pulmonary diseaseQiang Zhang, Yuanyi Yue, Rui ZhengBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 10, 2023
Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A reviewWei Song, Yuanyi Yue, Qiang ZhangInternational Immunopharmacology|June 4, 2023
Bioinformatics analysis of PLA2G7 as an immune-related biomarker in COPD by promoting expansion and suppressive functions of MDSCsXiaoyu Zhao, Yuanyi Yue, Xueqing Wang, et al.Tobacco Induced Diseases|April 8, 2020
Electronic cigarettes: Emerging trends and research hotspotsQiang Zhang, Xinyue Fan, Yuanyi Yue, et al.Cancer Science|February 15, 2023
STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting Mcl-1-dependent cytoprotective autophagyYuanyi Yue, Qiang Zhang, Xueqing Wang, et al.The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|November 1, 2018
A Bibliometric Analysis of Cleft Lip and Palate-Related Publication Trends From 2000 to 2017Qiang Zhang, Yuanyi Yue, Bei Shi, et al.Frontiers in Physiology|June 17, 2024
Copper homeostasis dysregulation in respiratory diseases: a review of current knowledgeWei Song, Yuanyi Yue, Qiang Zhang, et al.Aging Cell|July 3, 2024
SCARF2 is a target for chronic obstructive pulmonary disease: Evidence from multi-omics research and cohort validationSai Wang, Yuanyi Yue, Xueqing Wang, et al.Microbiology and Immunology|May 21, 2021
Neurotrophic factor levels in the serum and cerebrospinal fluid of neonates infected with human cytomegalovirusShuang Wang, Fei Zou, Si Wu, et al.Pageof 2